Nypro expands; Jabil deal pushed back

Nypro's new facility will manufacture advanced respiratory and injectable devices for global healthcare and pharmaceutical customers. Nypro is hiring healthcare automation engineers and technicians, healthcare quality engineers and technicians, operations managers, program managers, team leaders and operators.

James O' Gorman, VP Drug Delivery and Diagnostics of Nypro Healthcare said, "Nypro has operated in Ireland in Bray since 1980 and in recent years our healthcare business has grown significantly. Our latest growth phase is built upon the skills, work ethic, creativity and drive of our Nypro Ireland team."

Ireland is pumping money into the project in an effort to reverse job losses in the southeastern coastal section of Ireland. "Let this be part of the fightback of Waterford and the southeast region, to claim its rightful place as an attractive location for investment and job creation in our country," one official was quoted as saying.

It was announced Feb 4 that Nypro's directors had agreed to be purchased by Jabil Circuit for $665 million.  At the time, Jabil said that the deal was expected to close in May. But the timetable has been pushed pack for unexplained reasons.

In a conference call with financial analysts, Jabil Circuit CEO  Mark  Mondello said: "As far as the Nypro business, the way things look today, we feel like we're going to close the Nypro deal if everything goes as planned in the very early part of Q4." Jabil's fiscal year ends Aug. 31.

Mondello replaced Timothy Main as Jabil CEO since the Nypro deal was announced as part of a planned succession.